The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Ruto Says US Plan to Build Ebola Facility in Kenya Is the 'right Thing'

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

US Domestic Treatment Centers Ready for Ebola Even as Kenya Plans Persist

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Says Kidney Disease Drug Preserves Function in Late-stage Study

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

How Doctors’ Regrets Evolve — and What to Do With Yours

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Obexelimab Lowers Flare Risk in Phase 3 IgG4-RD Trial

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

News All Time

Executive Order on Vaccines Defies Federal Ruling

Any attempt to change the vaccine schedule without proper process and evidence will invite further legal action, say attorney for physician groups.

Asthma Control: How Much ICS Is Enough?

Low-dose ICS remain essential for every asthma patient, and GINA/CFA guidance favors phenotype-tailored step-up strategies rather than routine dose escalation to prevent exacerbations.

Early Peanut Immunotherapy May Yield Long-Term Benefits

Early peanut oral immunotherapy may confer lasting immune benefits, with most young patients continuing to consume peanuts years later and only a few reporting allergic reactions.

Are Saliva and Urine Rheumatology’s Next Biomarker Frontier?

Recent studies suggest that saliva and urine may provide clinically relevant biomarker information in Sjögren syndrome, rheumatoid arthritis, and lupus nephritis.

Health Officials Oppose US Plan to Treat Ebola-exposed Americans Overseas

Healthcare officials in the U.S., including former Centers for Disease Control and Prevention officials, on Monday warned ⁠Congress against adopting a proposed policy to...

Is America Bioprepared for the Next Outbreak?

As Ebola and hantavirus outbreaks unfold globally, Drs Robert Glatter and Syra Madad discuss preparedness, hospital readiness, training, and the growing complexity of infectious disease threats.

Plasma Exchange Buys Time for Liver Failure Patients

Plasma exchange with 5% albumin improved 90-day survival in selected patients with acute-on-chronic liver failure, offering the first positive survival study in the field.

Ensitrelvir Earns Approval for Postexposure COVID Protection

Oral antiviral offers 5-day regimen to protect teens and adults after exposure.

MHRA Authorises Rilzabrutinib for Adult ITP

The MHRA has authorised rilzabrutinib for adults with ITP where prior therapies have failed, based on phase 3 data showing durable platelet response.

On-Screen ER: What ‘The Pitt’ Gets Right

An emergency physician praises The Pitt’s second season for realistically portraying ER teamwork, human connection, and crisis response despite dramatic compression of events.

A Partially Hydrolyzed Formula May Cut Childhood Allergies

A randomized study suggests a partially hydrolyzed formula fed from 0 to 6 months may reduce risks of food allergy, atopic dermatitis, and any allergy up to age 5.

Ethnic Disparities in Bacteraemia and Resistance in England

In England, younger ethnic minority groups, especially women, have higher rates of E coli bloodstream infection; antibiotic resistance is notably higher in Asian individuals and care home residents.

Replimune Gets Third Chance At US Approval for Skin Cancer Drug

Replimune said on Friday it plans to apply a third time for approval of its experimental skin cancer drug in the coming days ⁠after reaching an agreement with the U.S....

Indoor Fragrances: Are Overlooked Health Risks Growing?

Daily exposure to indoor fragrances is drawing growing concern as clinicians report rising allergies, asthma, and air quality problems linked to scented products.

Kids’ Food Allergy May Take an Emotional Toll on Parents

Parents of children with food allergies may experience a greater psychosocial burden when reactions are more frequent or severe and when families follow stricter allergenic food avoidance practices.

Race Car Driver’s Death and Pneumonia Risks

The tragic death of a 41-year-old NASCAR champion from pneumonia and sepsis is a reminder that the conditions can strike at any age and progress quickly.

Recommended News For You

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Recommended Articles For You

Understanding Lymphedema: Symptoms, Causes, and Treatment  

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late 

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

The pathology of incurable cancers can be predicted thanks to research.

4.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

5.

Measurable Residual Disease Predicts Real-World AML Relapse

1.

The Benefits and Side Effects of Vidaza Syndrome 

2.

The Unseen Danger of Anal Cancer: How to Protect Yourself

3.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

4.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

5.

Unlocking the Potential of Palbociclib: A Comprehensive Overview

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Lung Cancer Congress®

5.

Genito-Urinary Oncology Summit 2026

1.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part XIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot